StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.18−0.23 (-5.22%)

Close on Nov 17, 2026Market cap $103.61MP/E –Yield –

Lexaria Bioscience total assets

Total assets on the balance sheet at the end of each period.

Lexaria Bioscience's total assets was $4.78M at May 31, 2026. For fiscal 2025 it was $4.18M, down 52.9% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $13.27M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Aug 31, 2025$4.18M-52.9%
FY2024Aug 31, 2024$8.87M+187.5%
FY2023Aug 31, 2023$3.08M-60.6%
FY2022Aug 31, 2022$7.83M-41.0%
FY2021Aug 31, 2021$13.27M+369.1%
FY2020Aug 31, 2020$2.83M+5.7%
FY2019Aug 31, 2019$2.68M+10.0%
FY2018Aug 31, 2018$2.43M-15.0%
FY2017Aug 31, 2017$2.86M+404.8%
FY2016Aug 31, 2016$566.64K-20.4%
FY2015Aug 31, 2015$711.72K-80.1%
FY2013Oct 31, 2013$3.57M-14.8%
FY2012Oct 31, 2012$4.19M-3.4%
FY2011Oct 31, 2011$4.34M+32.4%
FY2010Oct 31, 2010$3.28M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026May 31, 2026$4.78M-29.1%
Q2 FY2026CQ1 2026Feb 28, 2026$6.49M-25.2%
Q1 FY2026CQ4 2025Nov 30, 2025$6.05M-38.2%
Q4 FY2025CQ3 2025Aug 31, 2025$4.18M-52.9%
Q3 FY2025CQ2 2025May 31, 2025$6.74M-32.7%
Q2 FY2025CQ1 2025Feb 28, 2025$8.68M+36.6%
Q1 FY2025CQ4 2024Nov 30, 2024$9.79M+170.0%
Q4 FY2024CQ3 2024Aug 31, 2024$8.87M+187.5%
Q3 FY2024CQ2 2024May 31, 2024$10.02M+91.2%
Q2 FY2024CQ1 2024Feb 29, 2024$6.35M+30.8%
Q1 FY2024CQ4 2023Nov 30, 2023$3.63M-41.6%
Q4 FY2023CQ3 2023Aug 31, 2023$3.08M-60.6%
Q3 FY2023CQ2 2023May 31, 2023$5.24M-42.7%
Q2 FY2023CQ1 2023Feb 28, 2023$4.85M-57.5%
Q1 FY2023CQ4 2022Nov 30, 2022$6.21M-47.1%
Q4 FY2022CQ3 2022Aug 31, 2022$7.83M-41.0%
Q3 FY2022CQ2 2022May 31, 2022$9.14M-13.4%
Q2 FY2022CQ1 2022Feb 28, 2022$11.41M-6.2%
Q1 FY2022CQ4 2021Nov 30, 2021$11.75M+440.2%
Q4 FY2021CQ3 2021Aug 31, 2021$13.27M+369.1%
Q3 FY2021CQ2 2021May 31, 2021$10.55M+217.7%
Q2 FY2021CQ1 2021Feb 28, 2021$12.17M+512.8%
Q1 FY2021CQ4 2020Nov 30, 2020$2.17M-20.8%
Q4 FY2020CQ3 2020Aug 31, 2020$2.83M+5.7%
Q3 FY2020CQ2 2020May 31, 2020$3.32M-4.0%
Q2 FY2020CQ1 2020Feb 29, 2020$1.99M-53.5%
Q1 FY2020CQ4 2019Nov 30, 2019$2.75M-22.5%
Q4 FY2019CQ3 2019Aug 31, 2019$2.68M+10.0%
Q3 FY2019CQ2 2019May 31, 2019$3.46M+27.6%
Q2 FY2019CQ1 2019Feb 28, 2019$4.27M+50.4%
Q1 FY2019CQ4 2018Nov 30, 2018$3.54M+41.9%
Q4 FY2018CQ3 2018Aug 31, 2018$2.43M-15.0%
Q3 FY2018CQ2 2018May 31, 2018$2.71M-13.8%
Q2 FY2018CQ1 2018Feb 28, 2018$2.84M+226.9%
Q1 FY2018CQ4 2017Nov 30, 2017$2.50M+119.7%
Q4 FY2017CQ3 2017Aug 31, 2017$2.86M+404.8%
Q3 FY2017CQ2 2017May 31, 2017$3.14M–
Q2 FY2017CQ1 2017Feb 28, 2017$869.12K–
Q1 FY2017CQ4 2016Nov 30, 2016$1.14M–
Q4 FY2016CQ3 2016Aug 31, 2016$566.64K–

More Lexaria Bioscience figures

See a number that looks wrong?